HansBiomed Valuation
| 042520 Stock | KRW 7,490 10.00 0.13% |
At this time, the firm appears to be overvalued. HansBiomed retains a regular Real Value of W6141.8 per share. The prevalent price of the firm is W7490.0. Our model calculates the value of HansBiomed from evaluating the firm fundamentals such as Current Valuation of 184.7 B, return on equity of 13.65, and Return On Asset of -0.0946 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that HansBiomed's price fluctuation is very steady at this time. Calculation of the real value of HansBiomed is based on 3 months time horizon. Increasing HansBiomed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since HansBiomed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HansBiomed Stock. However, HansBiomed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7490.0 | Real 6141.8 | Hype 7490.0 | Naive 7223.86 |
The real value of HansBiomed Stock, also known as its intrinsic value, is the underlying worth of HansBiomed Company, which is reflected in its stock price. It is based on HansBiomed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of HansBiomed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of HansBiomed helps investors to forecast how HansBiomed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HansBiomed more accurately as focusing exclusively on HansBiomed's fundamentals will not take into account other important factors: HansBiomed Total Value Analysis
HansBiomed is presently forecasted to have takeover price of 184.7 B with market capitalization of 112.74 B, debt of 1.35 B, and cash on hands of 7.52 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the HansBiomed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
184.7 B | 112.74 B | 1.35 B | 7.52 B |
HansBiomed Investor Information
About 28.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from HansBiomed's historical financial statements, HansBiomed is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.HansBiomed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. HansBiomed has an asset utilization ratio of 56.54 percent. This suggests that the Company is making W0.57 for each dollar of assets. An increasing asset utilization means that HansBiomed is more efficient with each dollar of assets it utilizes for everyday operations.HansBiomed Ownership Allocation
The market capitalization of HansBiomed is W112.74 Billion. HansBiomed secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.HansBiomed Profitability Analysis
The company reported the revenue of 74.46 B. Net Income was 4.92 B with profit before overhead, payroll, taxes, and interest of 29.23 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates HansBiomed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in HansBiomed and how it compares across the competition.
About HansBiomed Valuation
The stock valuation mechanism determines HansBiomed's current worth on a weekly basis. Our valuation model uses a comparative analysis of HansBiomed. We calculate exposure to HansBiomed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of HansBiomed's related companies.HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea. HANS BIOMED is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct HansBiomed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates HansBiomed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct HansBiomed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain HansBiomed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine HansBiomed's revenue streams: Identify HansBiomed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research HansBiomed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish HansBiomed's growth potential: Evaluate HansBiomed's management, business model, and growth potential.
- Determine HansBiomed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate HansBiomed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for HansBiomed Stock analysis
When running HansBiomed's price analysis, check to measure HansBiomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HansBiomed is operating at the current time. Most of HansBiomed's value examination focuses on studying past and present price action to predict the probability of HansBiomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HansBiomed's price. Additionally, you may evaluate how the addition of HansBiomed to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |